secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2025-12-02T23:59:59+00:00
Accession:  0001534120-25-000022
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalo posts updated investor presentation; no specific new data disclosed
-------------------------------------------------------------------------

- Company filed 8-K announcing updated investor presentation posted on its website.
- Presentation is a corporate overview focused on IL-1β therapies pipeline.
- No financial results, trial data, or guidance changes included in the filing text.
- Presentation will be used in meetings with investors going forward.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000153412025000022/0001534120-25-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000153412025000022/avtx-20251202.htm
  HTML page:      https://secwatch.observer/filing/0001534120-25-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer